Data investigation

What Makes a Telehealth GLP-1 Prescription Legitimate

The FDA publishes seven warning signs for telehealth medicine sellers, and almost nobody quotes them. Here they are, with what proper prescribing looks like and the one disclosure 139 of our 560 sellers fail.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
7 min read·1 citations

Almost every GLP-1 sold in the United States now arrives through a website. That is not in itself a problem — telehealth prescribing is ordinary, legal medicine. What varies enormously is how much of it actually happens. The FDA publishes its own list of warning signs for exactly this situation, and it is a sharper checklist than most of what gets written about buying online.[1]

The FDA's own red flags

These are the agency’s, not ours. It tells consumers to look out for a company that:[1]

  • claims the compounded drug is the same as an FDA-approved drug
  • offers medicine at deep discounts, or prices that seem too good to be true
  • sends medicine that looks different from what you previously received or what was pictured on the site, or that arrives in broken or damaged packaging, or without instructions for use
  • does not require a screening and prescription by a licensed doctor before providing medicine
  • has no licensed doctor available to answer questions after you receive the medication
  • makes spelling errors on the label, or gives an incorrect address for the pharmacy
  • puts a pharmacy name on the label that you suspect is fraudulent

Two of those deserve pulling out, because they describe the whole business model of the worst operators rather than a slip. A service that does not require screening and a prescription from a licensed doctor is not a fast telehealth service; it is not prescribing at all. And a service with no doctor reachable after delivery has sold you a product rather than provided care — which matters most at exactly the moment something goes wrong.

What good prescribing looks like

The FDA’s baseline is simple to state: compounded drugs should only be used by patients whose medical needs cannot be met by an FDA-approved drug, patients should obtain a prescription from their doctor, and should fill it at a state-licensed pharmacy.[1] Everything below follows from that.

  1. A licensed clinician evaluates you before anything is prescribed. How that happens — video, phone, or a written exchange — is set by state law and varies. That an evaluation happens at all does not vary.
  2. That clinician is licensed in your state, not merely somewhere. This is the requirement most often quietly missing, and the one a buyer can rarely verify from the outside.
  3. The intake asks questions that could change the answer. A form that cannot produce a ‘no’ is not a screening. Thyroid cancer in the family, MEN 2, a pancreatitis history, pregnancy and whatever else you take all belong in it.
  4. A named pharmacy dispenses it. Not “a licensed US compounding pharmacy” — a name you can look up.
  5. Someone is reachable afterward. Dose changes, side effects and the decision to stop are all clinical events, and they all happen after the first shipment.
Platform or prescriber? Read the footer. A great many sites state plainly that they do not practice medicine, do not write prescriptions and do not dispense — they connect you to independent providers and pharmacies. That disclosure is honest and it is also load-bearing: it tells you who is responsible when something goes wrong, and it is usually not the brand whose name is on the box.

The disclosure gap we can measure

Of the 560 sellers in our register, 139 carry a note from our reviewer that the compounding pharmacy is not named anywhere on the site. That is a floor rather than a total — it counts only the records where someone wrote it down — and it is the single most common disclosure failure we record.

It matters more than it looks. The pharmacy is who actually made the thing you inject. Without a name there is no state license to check, no inspection history, and no way to act on the FDA’s advice to contact the compounder with questions.[1] It also makes the label-fraud problem unanswerable from your side, which we cover in is the vial you received what the label says.

“A licensed US compounding pharmacy” is a category, not an answer. Ask which one.

The question is worth asking directly, before you buy, in writing. A seller that answers it plainly has told you something good about itself. A seller that will not is telling you something too. Our comparison tool filters on what each one discloses.

Where to check things yourself

  • The FDA’s BeSafeRx campaign is the agency’s own resource for buying prescription medicines online safely, and it is the first place to send anyone who is unsure.[1]
  • Your state board of pharmacy holds the license record for any pharmacy that names itself.
  • Your state medical board holds the license record for a named prescriber, including whether it covers your state.
  • The seller itself. The FDA specifically suggests contacting the compounder or the telehealth platform you bought from with questions about the label or instructions for use.[1]
None of this is a reason to avoid telehealth. Distance care is how a great many people get treatment they would otherwise not get at all, and the alternative for most readers is not a better clinic — it is no clinic. The point is that the checks above take about ten minutes and are the difference between telehealth and a storefront.

Frequently Asked Questions

References

  1. 1.U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — drug alert, including telehealth red flags for consumers; content current as of June 15, 2026 FDA. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

BPC-157: What FDA Actually Said About It

Not approved, and not on the list a compounding pharmacy may use. FDA recorded specific concerns — immunogenicity, peptide impurities, and “no, or only limited, safety-related information”.

7 min read

CJC-1295 and Ipamorelin: What FDA Recorded

Sold as a stack for fat loss. FDA identified serious adverse events with CJC-1295 — increased heart rate and systemic vasodilatory reaction — and neither peptide has a weight-loss trial.

7 min read

Is the Vial You Received What the Label Says?

FDA has found labels naming compounding pharmacies that do not exist, and labels naming real pharmacies that did not make the product. What to check when the box arrives, and what the 990 adverse event reports actually mean.

8 min read

What Cannot Legally Be Compounded — and Who Is Selling It Anyway

Federal law bars retatrutide and cagrilintide from compounding entirely. We checked our own 560-seller register against that rule, found 7 with it on the menu, and discovered our own reviews were not telling readers.

8 min read

Do GLP-1 Patches Work? The Molecule Is Too Big

Skin stops molecules above roughly 500 daltons. Semaglutide weighs 4,114 and tirzepatide 4,813. No adhesive patch changes that, and no GLP-1 patch is FDA-approved.

7 min read

HCG, B12 and Lipotropic Shots: What the Labels and the FDA Say

HCG's own FDA-approved labeling states there is no substantial evidence it increases weight loss beyond caloric restriction. The 500-calorie diet it is sold with is the part that works — and the part that is dangerous.

6 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.5

Strut Health

Semaglutide at $99/month, 48% under the register median

6.8

Care Bare Rx

Knowing which pharmacy fills the vial — it names Belmar Pharmacy

7.9

Oak

Semaglutide at $119/month, 37% under the register median